Military personnel are outraged over the nearly $726 million spent on weight loss medications, viewing it as a misguided response to the obesity crisis within the U.S. Armed Forces. A 2025 report from the American Security Project reveals that about 68 percent of National Guard and Reserve members are classified as overweight. Secretary of War Pete Hegseth has publicly condemned this situation, stating, “Completely unacceptable. This is what happens when standards are IGNORED… and this is what we are changing. REAL fitness & weight standards are here. We will be FIT, not FAT.”
Despite the intention to raise fitness standards, many are questioning the strategy. RealClearInvestigations labeled the military’s funding of GLP-1 weight loss medications, including Ozempic, Wegovy, and Trulicity, as the “Waste of the Day.” From 2021 to now, the military has made 102,597 individual purchases and directed most of the funds toward the pharmaceutical company Cencora. This approach has angered those with military experience.
Lt. Ted Macie, a retired Navy Medical Service Corps officer, criticized the expenditure as “yet another bandage on a broken leg” and highlighted that obesity rates have surged dramatically—rising from 13,863 cases in 2016 to 2019 to 21,969 cases from 2020 to 2023. This shocking rise of roughly 190 percent prompted Macie to denounce the military’s short-sightedness in addressing such a fundamental issue, warning of future health consequences tied to the medication spending.
“Odds are, we’ll be paying for the downstream health consequences later, too,” warned Macie, who has actively promoted fitness and nutrition. His frustration stems from the contradictory messages the military sends when overweight service members are promoted, undermining the supposed commitment to readiness. “These commanders can’t preach fitness while rewarding the opposite,” he noted, criticizing what he sees as a failure to enforce proper standards.
Another voice of concern comes from U.S. Army Sergeant First Class Josh Snodgrass, a retired paratrooper who served for 20 years. He questioned the long-term implications of widespread pharmaceutical interventions and how the military found itself in a situation where such a drastic measure was necessary. Snodgrass described his own experience, stating that in the last years of his service, issues with weight control became more prevalent—not just in combat arms but also in support roles. He believes that lax enforcement of fitness standards begins at basic training, where discipline and accountability must be established.
While recognizing genuine medical issues, Snodgrass insists that the $726 million spent raises questions about fitness for duty. “At some point,” he stated, “you have to ask whether someone who requires ongoing pharmaceutical support to meet basic physical standards is fit for service in the first place.” He argued that the funds could have been allocated in a manner that would have meaningfully bolstered combat readiness.
An anonymous Army Green Beret echoed these sentiments, expressing disbelief over the military’s decisions. The Green Beret found the spending “outrageous,” emphasizing a disconnect between the military’s proclaimed standards of fitness and the expenses on weight loss drugs. He raised concerns that without a clear vetting process for these medications, there is a significant risk of misuse.
As military leaders continue to grapple with rising obesity rates among their ranks, the response seems ill-fitted to tackle a complex issue that requires more than temporary solutions. For veterans and current service members, the spending raises alarm bells, highlighting a critical need for accountability and a reevaluation of how fitness standards are enforced across the military.
"*" indicates required fields
